Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 15 Nov 2021 08:00 CET |
KBC | KBC Groep: 15 november 2021 – informatie m.b.t. traditionele jaarlijkse kapitaalverhoging voor het personeel | 30101010 Banks | Other subject |
| 15 Nov 2021 07:45 CET |
KBC | KBC Groupe: KBC acquiert les opérations bulgares de Raiffeisen Bank International | 30101010 Banks | Mergers, Acquiqitions, Transferts |
| 15 Nov 2021 07:45 CET |
KBC | KBC Groep: KBC neemt de Bulgaarse activiteiten van Raiffeisen Bank International over | 30101010 Banks | Mergers, Acquiqitions, Transferts |
| 15 Nov 2021 07:45 CET |
KBC | KBC Group: KBC acquires Bulgarian operations of Raiffeisen Bank International | 30101010 Banks | Mergers, Acquiqitions, Transferts |
| 15 Nov 2021 07:00 CET |
HYLORIS | Hyloris Announces Earlier than Expected PDUFA Date for Maxigesic® IV | 20103010 Biotechnology | Other subject |
| 15 Nov 2021 07:00 CET |
VGP | VGP NV: Voting Rights and Denominator | 35101010 Real Estate Holding and Development | Other subject |
| 15 Nov 2021 07:00 CET |
HYLORIS | Hyloris annonce la date PDUFA plus tôt que prévue pour Maxigesic® IV | 20103010 Biotechnology | Other subject |
| 15 Nov 2021 07:00 CET |
VGP | VGP NV: Stemrechten en Noemer | 35101010 Real Estate Holding and Development | Other subject |
| 12 Nov 2021 22:30 CET |
NYXOAH SA | Nyxoah Announces Participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference | 20102010 Medical Equipment | Other subject |
| 12 Nov 2021 22:30 CET |
NYXOAH SA | Nyxoah Annonce sa Participation à la Piper Sandler 33rd Annual Virtual Healthcare Conference | 20102010 Medical Equipment | Other subject |
| 12 Nov 2021 18:17 CET |
CRESCENT | GEREGLEMENTEERDE INFORMATIE - Openbaarmaking over een transparantiekennisgeving (artikel 14, eerste lid, van de wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen) | 15101010 Telecommunications Equipment | Other subject |
| 12 Nov 2021 18:16 CET |
CRESCENT | REGULATED INFORMATION - Disclosure of a transparency notification (Article 14(1) of the Law of 2 May 2007 on disclosure of major holdings) | 15101010 Telecommunications Equipment | Other subject |
| 12 Nov 2021 13:00 CET |
CELYAD ONCOLOGY | Celyad Oncology présente des données précliniques sur le programme de thérapie allogénique CAR T et précise le concept de l'essai clinique KEYNOTE-B79 lors de la 36e réunion annuelle de la Society for Immunotherapy of Cancer (SITC) | 20103010 Biotechnology | Other subject |
| 12 Nov 2021 13:00 CET |
CELYAD ONCOLOGY | Celyad Oncology Presents Preclinical Data on Allogeneic CAR T Therapy Program and Highlights KEYNOTE-B79 Clinical Trial Design at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting | 20103010 Biotechnology | Other subject |
| 12 Nov 2021 08:00 CET |
TEXAF | Texaf : INFORMATION TRIMESTRIELLE | 35101010 Real Estate Holding and Development | Other subject |
| 12 Nov 2021 08:00 CET |
TEXAF | Texaf: KWARTAALINFORMATIE | 35101010 Real Estate Holding and Development | Other subject |
| 12 Nov 2021 08:00 CET |
TEXAF | Texaf: INTERIM STATEMENT | 35101010 Real Estate Holding and Development | Other subject |
| 12 Nov 2021 07:00 CET |
KBC | KBC Groep: Resultaat derde kwartaal van 601 miljoen euro | 30101010 Banks | Commercial results |
| 12 Nov 2021 07:00 CET |
KBC | KBC Group: Third-quarter result of 601 million euros | 30101010 Banks | Commercial results |
| 12 Nov 2021 07:00 CET |
KBC | KBC Groupe: Bénéfice de 601 millions d'euros au troisième trimestre | 30101010 Banks | Commercial results |
| 11 Nov 2021 08:38 CET |
TITAN CEMENT | Résultats des neuf premiers mois 2021 | 50101030 Cement | Commercial results |
| 11 Nov 2021 08:37 CET |
TITAN CEMENT | Nine Month 2021 Results | 50101030 Cement | Commercial results |
| 11 Nov 2021 08:23 CET |
EXMAR ord. | Exmar Update liquiditeitspositie | 50206030 Marine Transportation | Corporate life |
| 11 Nov 2021 08:21 CET |
EXMAR ord. | Exmar Update Liquidity Position | 50206030 Marine Transportation | Corporate life |
| 10 Nov 2021 22:05 CET |
CELYAD ONCOLOGY | Celyad Oncology Announces Third Quarter 2021 Financial Results and Recent Business Highlights | 20103010 Biotechnology | Other subject |
| 10 Nov 2021 22:05 CET |
CELYAD ONCOLOGY | Celyad Oncology publie ses résultats financiers du troisième trimestre 2021 et les avancées récentes des activités de la Société | 20103010 Biotechnology | Other subject |
| 10 Nov 2021 17:21 CET |
HYBRID SOFTWARE GROUP PLC | Hybrid Software Group PLC: Notification of transactions in shares by persons discharging managerial responsibility | 10101015 Software | Other subject |
| 10 Nov 2021 07:30 CET |
AGEAS | Ageas rapporteert resultaten voor de eerste negen maanden van 2021 | 30301010 Life Insurance | Other financial transaction |
| 10 Nov 2021 07:30 CET |
AGEAS | Ageas reports on its nine month results 2021 | 30301010 Life Insurance | Other financial transaction |
| 10 Nov 2021 07:30 CET |
AEDIFICA | Aedifica NV/SA: Interim statement from the Board of Directors – 3rd quarter 2021 | 35102010 Health Care REITs | Commercial results |
| 10 Nov 2021 07:30 CET |
AGEAS | Ageas publie ses résultats pour les 9 premiers mois de 2021 | 30301010 Life Insurance | Other financial transaction |
| 10 Nov 2021 07:00 CET |
ARGENX SE | argenx to Present at Upcoming Investor Conferences | 20103010 Biotechnology | Other subject |
| 10 Nov 2021 07:00 CET |
BIOCARTIS | Press release Biocartis Group NV: Biocartis Q3 2021 Business Update | 20101025 Health Services | Commercial results |
| 10 Nov 2021 07:00 CET |
HYLORIS | Hyloris Broadens Pipeline with Novel Patented Combination Product Candidate in Acute Myeloid Leukaemia and Small Cell Lung Cancer | 20103010 Biotechnology | Other subject |
| 10 Nov 2021 07:00 CET |
BIOCARTIS | Persbericht Biocartis Group NV: Biocartis Q3 2021 Business Update | 20101025 Health Services | Commercial results |
| 10 Nov 2021 07:00 CET |
HYLORIS | Hyloris élargit son portefeuille avec une nouvelle combinaison brevetée de produit candidat dans la leucémie myéloïde aiguë et le cancer du poumon à petites cellules | 20103010 Biotechnology | Other subject |
| 09 Nov 2021 22:30 CET |
NYRSTAR | Nyrstar NV – Court revokes the appointment of experts and halts expert investigation | 55102050 Nonferrous Metals | Other subject |
| 09 Nov 2021 22:30 CET |
NYRSTAR | Nyrstar NV – Rechtbank vernietigt de aanstelling van deskundigen en zet deskundigenonderzoek stop | 55102050 Nonferrous Metals | Other subject |
| 09 Nov 2021 18:14 CET |
BPOST | bpost: Third quarter 2021 results | 50206040 Delivery Services | Legal |
| 09 Nov 2021 18:00 CET |
CARE PROPERTY INVEST | Publicatie van een transparantiekennisgeving | 35102040 Residential REITs | Legal |
| 09 Nov 2021 18:00 CET |
CARE PROPERTY INVEST | Publication of a transparency notification | 35102040 Residential REITs | Legal |
| 09 Nov 2021 17:58 CET |
BPOST | bpost: Third quarter 2021 results | 50206040 Delivery Services | Legal |
| 09 Nov 2021 17:56 CET |
BPOST | bpost: Third quarter 2021 results | 50206040 Delivery Services | Legal |
| 09 Nov 2021 17:45 CET |
CARE PROPERTY INVEST | Publication Interim Statement from the Board of Directors 3rd quarter 2021 | 35102040 Residential REITs | Commercial operations |
| 09 Nov 2021 17:45 CET |
CARE PROPERTY INVEST | Publicatie Tussentijdse Verklaring van de Raad van Bestuur 3de kwartaal 2021 | 35102040 Residential REITs | Commercial results |
| 09 Nov 2021 16:57 CET |
BARCO | Barco Leadership Update – November 9, 2021 | 10102030 Computer Hardware | New establishment |
| 09 Nov 2021 16:55 CET |
BARCO | Update Share Buyback Program | 10102030 Computer Hardware | Share history |
| 09 Nov 2021 16:54 CET |
BARCO | Transparency declaration by Titan Baratto NV: Threshold crossed | 10102030 Computer Hardware | Other subject |
| 09 Nov 2021 12:49 CET |
ASIT | Signature d’un avenant au contrat d’apport relatif à l’apport de la division imagerie médicale du groupe DMS à ASIT biotech | 20103010 Biotechnology | Other subject |
| 09 Nov 2021 07:45 CET |
AGFA-GEVAERT | Agfa-Gevaert Q3 results - Regulated information – November 9, 2021 - 7:45 a.m. CET | 50202025 Electronic Equipment: Gauges and Meters | Other subject |